companydata.dkFORWARD PHARMA A/S: Financial statements 2024
CVR: 28865880
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity amounted to DKK 488,330,233. The solvency ratio was 58.5%. The company had 2 employees in the financial year.
- Gross Profit
- -9,457,909 kr.
- Profit/Loss
- 75,927,645 kr.
- Equity
- 488,330,233 kr.
- Total Assets
- 835,352,476 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -9.5 mio. | 75.9 mio. | 488.3 mio. | 2 |
| 2023 | - | -6.1 mio. | -3.8 mio. | 426.4 mio. | 2 |
| 2022 | - | -11.6 mio. | -31.5 mio. | 430.4 mio. | 2 |
| 2021 | - | -10.8 mio. | -12.3 mio. | 461.9 mio. | 2 |
| 2020 | - | -7.8 mio. | -42.2 mio. | 474.1 mio. | 2 |
How creditworthy is FORWARD PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of September 4, 2024, Torsten Goesch has left the board of directors of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2023. Gross profit came to DKK -6,130,606, and the net result was DKK -3,832,516.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity amounted to DKK 488,330,233.